<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36154279</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Enterovirus D68 Infection in Human Primary Airway and Brain Organoids: No Additional Role for Heparan Sulfate Binding for Neurotropism.</ArticleTitle><Pagination><StartPage>e0169422</StartPage><MedlinePgn>e0169422</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01694-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.01694-22</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) is an RNA virus that can cause outbreaks of acute flaccid paralysis (AFP), a polio-like disease. Before 2010, EV-D68 was a rare pathogen associated with mild respiratory symptoms, but the recent EV-D68 related increase in severe respiratory illness and outbreaks of AFP is not yet understood. An explanation for the rise in severe disease is that it may be due to changes in the viral genome resulting in neurotropism. In this regard, in addition to sialic acid, binding to heparan sulfate proteoglycans (HSPGs) has been identified as a feature for viral entry of some EV-D68 strains in cell lines. Studies in human primary organotypic cultures that recapitulate human physiology will address the relevance of these HSPG-binding mutations for EV-D68 infection in vivo. Therefore, in this work, we studied the replication and neurotropism of previously determined sialic acid-dependent and HSPG-dependent strains using primary human airway epithelial (HAE) cultures and induced human pluripotent stem cell (iPSC)-derived brain organoids. All three strains (B2/2042, B2/947, and A1/1348) used in this study infected HAE cultures and human brain organoids (shown for the first time). Receptor-blocking experiments in both cultures confirm that B2/2042 infection is solely dependent on sialic acid, while B2/947 and A1/1348 (HSPG to a lesser extent) binds to sialic acid and HSPG for cell entry. Our data suggest that HSPG-binding can be used by EV-D68 for entry in human physiological models but offers no advantage for EV-D68 infection of brain cells. <b>IMPORTANCE</b> Recent outbreaks of enterovirus D68, a nonpolio enterovirus, is associated with a serious neurological condition in young children, acute flaccid myelitis (AFM). As there is no antiviral treatment or vaccine available for EV-D68 it is important to better understand how EV-D68 causes AFM and why only recent outbreaks are associated with AFM. We investigated if a change in receptor usage of EV-D68 increases the virulence of EV-D68 in the airway or the central nervous system and thus could explain the increase in AFM cases. We studied this using physiologically relevant human airway epithelium and cerebral organoid cultures that are physiologically relevant human models. Our data suggest that heparan sulfate proteoglycans can be used by EV-D68 as an additional entry receptor in human physiological models but offers no advantage for EV-D68 infection of brain cells, and our data show the potential of these 46 innovative models for virology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sridhar</LastName><ForeName>Adithya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2986-4884</Identifier><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology, OrganoVIR Labs, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Emma Children's Hospital Department of Pediatric Infectious Diseases, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Depla</LastName><ForeName>Josse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology, OrganoVIR Labs, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Emma Children's Hospital Department of Pediatric Infectious Diseases, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>uniQure Biopharma B.V., Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulder</LastName><ForeName>Lance A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology, OrganoVIR Labs, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Emma Children's Hospital Department of Pediatric Infectious Diseases, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karelehto</LastName><ForeName>Eveliina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology, OrganoVIR Labs, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Emma Children's Hospital Department of Pediatric Infectious Diseases, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouwer</LastName><ForeName>Lieke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology, OrganoVIR Labs, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Emma Children's Hospital Department of Pediatric Infectious Diseases, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruiswijk</LastName><ForeName>Leonie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology, OrganoVIR Labs, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira de Sá</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>uniQure Biopharma B.V., Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meijer</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Institute for Public Health and Environment, Centre for Infectious Diseases Research and Laboratory Surveillance, Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evers</LastName><ForeName>Melvin M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>uniQure Biopharma B.V., Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Kuppeveld</LastName><ForeName>Frank J M</ForeName><Initials>FJM</Initials><AffiliationInfo><Affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht Universitygrid.5477.1, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pajkrt</LastName><ForeName>Dasja</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology, OrganoVIR Labs, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Emma Children's Hospital Department of Pediatric Infectious Diseases, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wolthers</LastName><ForeName>Katja C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Department of Medical Microbiology, OrganoVIR Labs, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019812">Heparan Sulfate Proteoglycans</NameOfSubstance></Chemical><Chemical><RegistryNumber>GZP2782OP0</RegistryNumber><NameOfSubstance UI="D019158">N-Acetylneuraminic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019812" MajorTopicYN="N">Heparan Sulfate Proteoglycans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019158" MajorTopicYN="N">N-Acetylneuraminic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009940" MajorTopicYN="N">Organoids</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cerebral organoids</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">enterovirus D68</Keyword><Keyword MajorTopicYN="N">human airway epithelial cultures (HAE)</Keyword><Keyword MajorTopicYN="N">neurotropism</Keyword><Keyword MajorTopicYN="N">receptors</Keyword></KeywordList><CoiStatement>The authors declare a conflict of interest. J.A.D., R.V.d.S. and M.M.E. are employees and/or shareholders of UniQure Biopharma B.V.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>26</Day><Hour>14</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36154279</ArticleId><ArticleId IdType="pmc">PMC9603061</ArticleId><ArticleId IdType="doi">10.1128/spectrum.01694-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schieble JH, Fox VL, Lennette EH. 1967. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol 85:297–310. doi:10.1093/oxfordjournals.aje.a120693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120693</ArticleId><ArticleId IdType="pubmed">4960233</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, Curns AT, Rogers SL, Brown BA, Conover C, Dominguez SR, Feikin DR, Gray S, Hassan F, Hoferka S, Jackson MA, Johnson D, Leshem E, Miller L, Nichols JB, Nyquist A-C, Obringer E, Patel A, Patel M, Rha B, Schneider E, Schuster JE, Selvarangan R, Seward JF, Turabelidze G, Oberste MS, Pallansch MA, Gerber SI, EV-D68 Working Group . 2015. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med 3:879–887. doi:10.1016/S2213-2600(15)00335-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer A, van der Sanden S, Snijders BEP, Jaramillo-Gutierrez G, Bont L, van der Ent CK, Overduin P, Jenny SL, Jusic E, van der Avoort HGAM, Smith GJD, Donker GA, Koopmans MPG. 2012. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology 423:49–57. doi:10.1016/j.virol.2011.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.11.021</ArticleId><ArticleId IdType="pubmed">22177700</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Asturias EJ, Hixon AM, Van Leer-Buter C, Niesters HGM, Tyler KL, Abzug MJ, Dominguez SR. 2018. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. Lancet Infect Dis 18:e239–e247. doi:10.1016/S1473-3099(18)30094-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Elrick MJ, Pekosz A, Duggal P. 2021. Enterovirus D68 molecular and cellular biology, and pathogenesis. J Biol Chem 296:100317. doi:10.1016/j.jbc.2021.100317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100317</ArticleId><ArticleId IdType="pmc">PMC7949111</ArticleId><ArticleId IdType="pubmed">33484714</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T, Okamoto M, Nakakita S-i, Suzuki A, Saito M, Tamaki R, Lupisan S, Roy CN, Hiramatsu H, Sugawara K-e, Mizuta K, Matsuzaki Y, Suzuki Y, Oshitani H. 2014. Antigenic and receptor binding properties of enterovirus 68. J Virol 88:2374–2384. doi:10.1128/JVI.03070-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03070-13</ArticleId><ArticleId IdType="pmc">PMC3958110</ArticleId><ArticleId IdType="pubmed">24371050</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng J, Baggen J, Meng G, Xiao C, Thibaut HJ, van Kuppeveld FJM, Rossmann MG. 2015. Sialic acid-dependent cell entry of human enterovirus D68. Nat Commun 6:8865. doi:10.1038/ncomms9865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9865</ArticleId><ArticleId IdType="pmc">PMC4660200</ArticleId><ArticleId IdType="pubmed">26563423</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Guo H, Chang J, Yu Y, Liu G, Zhang N, Willard SH, Zheng S, Yu X-F. 2016. ICAM-5/telencephalin is a functional entry receptor for enterovirus D68. Cell Host Microbe 20:631–641. doi:10.1016/j.chom.2016.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.09.013</ArticleId><ArticleId IdType="pubmed">27923705</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Liu Y, Lyoo H, van Vliet ALW, Wahedi M, de Bruin JW, Roberts RW, Overduin P, Meijer A, Rossmann MG, Thibaut HJ, van Kuppeveld FJM. 2019. Bypassing pan-enterovirus host factor PLA2G16. Nat Commun 10:3171. doi:10.1038/s41467-019-11256-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11256-z</ArticleId><ArticleId IdType="pmc">PMC6639302</ArticleId><ArticleId IdType="pubmed">31320648</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, et al. . 2016. Enterovirus D68 receptor requirements unveiled by haploid genetics (vol 113, pg 1399, 2016). P Natl Acad Sci USA 113:E1588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4747778</ArticleId><ArticleId IdType="pubmed">26787879</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V, Tseligka ED, Jones ST, Tapparel C. 2019. Heparan Sulfate proteoglycans and viral attachment: true receptors or adaptation bias? Viruses 11:596. doi:10.3390/v11070596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070596</ArticleId><ArticleId IdType="pmc">PMC6669472</ArticleId><ArticleId IdType="pubmed">31266258</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13–22. doi:10.1016/s0092-8674(00)80058-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)80058-6</ArticleId><ArticleId IdType="pubmed">10520990</ArticleId></ArticleIdList></Reference><Reference><Citation>Artpradit C, Robinson LN, Gavrilov BK, Rurak TT, Ruchirawat M, Sasisekharan R. 2013. Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles. Virus Res 176:69–77. doi:10.1016/j.virusres.2013.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.04.017</ArticleId><ArticleId IdType="pmc">PMC4145673</ArticleId><ArticleId IdType="pubmed">23707399</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelsson S, Gullberg M, Jonsson N, Roivainen M, Edman K, Lindberg AM. 2010. Studies of echovirus 5 interactions with the cell surface: heparan sulfate mediates attachment to the host cell. Virus Res 151:170–176. doi:10.1016/j.virusres.2010.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2010.05.001</ArticleId><ArticleId IdType="pubmed">20466025</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow IG, Sioofy AB, Powell RM, Evans DJ. 2001. Echoviruses bind heparan sulfate at the cell surface. J Virol 75:4918–4921. doi:10.1128/JVI.75.10.4918-4921.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.10.4918-4921.2001</ArticleId><ArticleId IdType="pmc">PMC114248</ArticleId><ArticleId IdType="pubmed">11312365</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Petty TJ, Schibler M, Martinez Y, Gerlach D, van Belle S, Turin L, Zdobnov E, Kaiser L, Tapparel C. 2012. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog 8:e1002826. doi:10.1371/journal.ppat.1002826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002826</ArticleId><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka ED, Sobo K, Stoppini L, Cagno V, Abdul F, Piuz I, Meylan P, Huang S, Constant S, Tapparel C. 2018. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog 14:e1007190. doi:10.1371/journal.ppat.1007190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayudhya SSN, et al.. 2020. Enhanced Enterovirus D68 replication in neuroblastoma cells is associated with a cell culture-adaptive amino acid substitution in VP1. Msphere 5:6. doi:10.1371/journal.ppat.1007190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC7643833</ArticleId><ArticleId IdType="pubmed">33148825</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T, Suzuki A, Lupisan S, Okamoto M, Aniceto R, Egos RJ, Daya EE, Tamaki R, Saito M, Fuji N, Roy CN, Opinion JM, Santo AV, Macalalad NG, Tandoc A, Sombrero L, Olveda R, Oshitani H. 2013. Molecular evolution of enterovirus 68 detected in the Philippines. PLoS One 8:e74221. doi:10.1371/journal.pone.0074221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074221</ArticleId><ArticleId IdType="pmc">PMC3779236</ArticleId><ArticleId IdType="pubmed">24073203</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Xie Z, Liu L, Ren L, Xiao Y, Paranhos-Baccalà G, Wang J. 2016. Genetic divergence of enterovirus D68 in China and the United States. Sci Rep 6:27800. doi:10.1038/srep27800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27800</ArticleId><ArticleId IdType="pmc">PMC4899779</ArticleId><ArticleId IdType="pubmed">27278628</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Sanz R, et al.. 2019. Enterovirus D68-associated respiratory and neurological illness in Spain, 2014–2018. Emerg Microbes Infect 8:1438–1444. doi:10.1080/22221751.2019.1668243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1668243</ArticleId><ArticleId IdType="pmc">PMC6781473</ArticleId><ArticleId IdType="pubmed">31571527</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar A, Simmini S, Ribeiro CMS, Tapparel C, Evers MM, Pajkrt D, Wolthers K. 2020. A perspective on organoids for virology research. Viruses 12:1341. doi:10.3390/v12111341.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12111341</ArticleId><ArticleId IdType="pmc">PMC7700289</ArticleId><ArticleId IdType="pubmed">33238561</ArticleId></ArticleIdList></Reference><Reference><Citation>Karelehto E, Cristella C, Yu X, Sridhar A, Hulsdouw R, de Haan K, van Eijk H, Koekkoek S, Pajkrt D, de Jong MD, Wolthers KC. 2018. Polarized entry of human parechoviruses in the airway epithelium. Front Cell Infect Microbiol 8:294. doi:10.3389/fcimb.2018.00294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00294</ArticleId><ArticleId IdType="pmc">PMC6119779</ArticleId><ArticleId IdType="pubmed">30211126</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan S, Sebo P, Osicka R. 2018. A guide to polarized airway epithelial models for studies of host-pathogen interactions. FEBS J 285:4343–4358. doi:10.1111/febs.14582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14582</ArticleId><ArticleId IdType="pubmed">29896776</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman MC, Wells AI, Ciomperlik-Patton J, Myerburg MM, Yang L, Konopka-Anstadt J, Coyne CB. 2021. Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates. Elife 10. doi:10.7554/eLife.66687.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.66687</ArticleId><ArticleId IdType="pmc">PMC8285104</ArticleId><ArticleId IdType="pubmed">34196272</ArticleId></ArticleIdList></Reference><Reference><Citation>Boda B, Benaoudia S, Huang S, Bonfante R, Wiszniewski L, Tseligka ED, Tapparel C, Constant S. 2018. Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium model. Antiviral Res 156:72–79. doi:10.1016/j.antiviral.2018.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.06.007</ArticleId><ArticleId IdType="pmc">PMC7113743</ArticleId><ArticleId IdType="pubmed">29890184</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure F-X, Dulière V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M. 2020. Characterization and thydrolyses treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Rep Med 1:100059. doi:10.1016/j.xcrm.2020.100059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100059</ArticleId><ArticleId IdType="pmc">PMC7373044</ArticleId><ArticleId IdType="pubmed">32835306</ArticleId></ArticleIdList></Reference><Reference><Citation>Krenn V, Bosone C, Burkard TR, Spanier J, Kalinke U, Calistri A, Salata C, Rilo Christoff R, Pestana Garcez P, Mirazimi A, Knoblich JA. 2021. Organoid modeling of Zika and herpes simplex virus 1 infections reveals virus-specific responses leading to microcephaly. Cell Stem Cell 28:1362–1379. doi:10.1016/j.stem.2021.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.03.004</ArticleId><ArticleId IdType="pmc">PMC7611471</ArticleId><ArticleId IdType="pubmed">33838105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori N. 2014. Cerebral organoids model human brain development and microcephaly. Mov Disord 29:185–185. doi:10.1002/mds.25740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25740</ArticleId><ArticleId IdType="pubmed">24375826</ArticleId></ArticleIdList></Reference><Reference><Citation>Depla JA, Sogorb-Gonzalez M, Mulder LA, Heine VM, Konstantinova P, van Deventer SJ, Wolthers KC, Pajkrt D, Sridhar A, Evers MM. 2020. Cerebral organoids: a human model for AAV capsid selection and therapeutic transgene efficacy in the brain. Mol Ther Methods Clin Dev 18:167–175. doi:10.1016/j.omtm.2020.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2020.05.028</ArticleId><ArticleId IdType="pmc">PMC7327852</ArticleId><ArticleId IdType="pubmed">32637448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster MA, Corsini NS, Wolfinger S, Gustafson EH, Phillips AW, Burkard TR, Otani T, Livesey FJ, Knoblich JA. 2017. Guided self-organization and cortical plate formation in human brain organoids. Nat Biotechnol 35:659–666. doi:10.1038/nbt.3906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3906</ArticleId><ArticleId IdType="pmc">PMC5824977</ArticleId><ArticleId IdType="pubmed">28562594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Sam IC, Lee VS, Wong HV, Chan YF. 2017. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology 501:79–87. doi:10.1016/j.virol.2016.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallak LK, Spillmann D, Collins PL, Peeples ME. 2000. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74:10508–10513. doi:10.1128/jvi.74.22.10508-10513.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.22.10508-10513.2000</ArticleId><ArticleId IdType="pmc">PMC110925</ArticleId><ArticleId IdType="pubmed">11044095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu WY, Li JJ, Liang GD. 2011. How does cellular heparan sulfate function in viral pathogenicity? Biomed Environ Sci 24:81–87.</Citation><ArticleIdList><ArticleId IdType="pubmed">21440844</ArticleId></ArticleIdList></Reference><Reference><Citation>Monzon ME, Casalino-Matsuda SM, Forteza RM. 2006. Identification of glycosaminoglycans in human airway secretions. Am J Respir Cell Mol Biol 34:135–141. doi:10.1165/rcmb.2005-0256OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2005-0256OC</ArticleId><ArticleId IdType="pmc">PMC2644177</ArticleId><ArticleId IdType="pubmed">16195536</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroulios G, Brown T, Moreni G, Kondro D, Dei A, Eaves A, Louis S, Hou J, Chang W, Pajkrt D, Wolthers KC, Sridhar A, Simmini S. 2022. Apical-out airway organoids as a platform for studying viral infections and screening for antiviral drugs. Sci Rep 12:7673. doi:10.1038/s41598-022-11700-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11700-z</ArticleId><ArticleId IdType="pmc">PMC9089294</ArticleId><ArticleId IdType="pubmed">35538146</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira de Sa R, Canizares Luna M, Pasterkamp RJ. 2021. Advances in central nervous system organoids: a focus on organoid-based models for motor neuron disease. Tissue Eng Part C Methods 27:213–224. doi:10.1089/ten.TEC.2020.0337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ten.TEC.2020.0337</ArticleId><ArticleId IdType="pubmed">33446055</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong Z-J, Hor J-H, Ng S-Y, Winanto . 2019. Spinal cord organoids add an extra dimension to traditional motor neuron cultures. Neural Regen Res 14:1515–1516. doi:10.4103/1673-5374.255966.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.255966</ArticleId><ArticleId IdType="pmc">PMC6557099</ArticleId><ArticleId IdType="pubmed">31089045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawada J, Kaneda S, Kirihara T, Maroof A, Levi T, Eggan K, Fujii T, Ikeuchi Y. 2017. Generation of a motor nerve organoid with human stem cell-derived neurons. Stem Cell Rep 9:1441–1449. doi:10.1016/j.stemcr.2017.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.021</ArticleId><ArticleId IdType="pmc">PMC5831012</ArticleId><ArticleId IdType="pubmed">29107592</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen J, Revah O, Miura Y, Thom N, Amin ND, Kelley KW, Singh M, Chen X, Thete MV, Walczak EM, Vogel H, Fan HC, Paşca SP. 2020. Generation of functional human 3D cortico-motor assembloids. Cell 183:1913–1929. doi:10.1016/j.cell.2020.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.017</ArticleId><ArticleId IdType="pmc">PMC8711252</ArticleId><ArticleId IdType="pubmed">33333020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Clarke P, Tyler KL. 2019. Contemporary circulating enterovirus D68 strains infect and undergo retrograde axonal transport in spinal motor neurons independent of sialic acid. J Virol 93:16. doi:10.1128/JVI.00578-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00578-19</ArticleId><ArticleId IdType="pmc">PMC6675884</ArticleId><ArticleId IdType="pubmed">31167912</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DM, Hixon AM, Oldfield LM, Zhang Y, Novotny M, Wang W, Das SR, Shabman RS, Tyler KL, Scheuermann RH. 2018. Contemporary circulating enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells. mBio 9:5. doi:10.1128/mBio.01954-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01954-18</ArticleId><ArticleId IdType="pmc">PMC6191546</ArticleId><ArticleId IdType="pubmed">30327438</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuse Y, Chaimongkol N, Okamoto M, Oshitani H. 2019. Evolutionary and functional diversity of the 5' untranslated region of enterovirus D68: increased activity of the internal ribosome entry site of viral strains during the 2010s. Viruses 11:626. doi:10.3390/v11070626.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070626</ArticleId><ArticleId IdType="pmc">PMC6669567</ArticleId><ArticleId IdType="pubmed">31288421</ArticleId></ArticleIdList></Reference><Reference><Citation>Agol VI. 1991. The 5'-untranslated region of picornaviral genomes. Adv Virus Res 40:103–180. doi:10.1016/S0065-3527(08)60278-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(08)60278-X</ArticleId><ArticleId IdType="pmc">PMC7130636</ArticleId><ArticleId IdType="pubmed">1957717</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor PD, Macadam AJ, Stone DM, Almond JW. 1993. Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 21:357–363. doi:10.1006/biol.1993.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/biol.1993.1096</ArticleId><ArticleId IdType="pubmed">8024751</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld AB, Warren AL, Racaniello VR. 2019. Neurotropism of enterovirus D68 isolates is independent of sialic acid and is not a recently acquired phenotype. mBio 10:5. doi:10.1128/mBio.02370-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02370-19</ArticleId><ArticleId IdType="pmc">PMC6805996</ArticleId><ArticleId IdType="pubmed">31641090</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BD, Pekosz A. 2020. Contemporary enterovirus D68 strains show enhanced replication and translation at 37°C. bioRxiv. doi:10.1101/2020.03.31.019380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.31.019380</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. American J Epidemiology 27:493–497. doi:10.1093/oxfordjournals.aje.a118408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Beld M, Minnaar R, Weel J, Sol C, Damen M, van der Avoort H, Wertheim-van Dillen P, van Breda A, Boom R. 2004. Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control. J Clin Microbiol 42:3059–3064. doi:10.1128/JCM.42.7.3059-3064.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.42.7.3059-3064.2004</ArticleId><ArticleId IdType="pmc">PMC446274</ArticleId><ArticleId IdType="pubmed">15243060</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>